Isabel G. C.
- Country
- Spain
- Department
- Pediatric endocrinology
Research Overview
- Efficacy and Safety of Lonapegsomatropin Versus Somatropin in Children and Adolescents with Growth Failure or Short Stature Due to GH-Sufficient Disorders
- Efficacy and Safety Evaluation of ALXN1850 in Pediatric Patients with Hypophosphatasia: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study
Data & Insights
Has run more than one trial at 5 of 37 partner sites.
Specializations
Pediatric Metabolic Disorders
This investigator specializes in studying hypophosphatasia (HPP), a rare inherited metabolic disorder affecting bone development and mineralization in pediatric patients.
- Pediatric bone disorders
- Metabolic bone diseases
- Rare genetic conditions
The research focus encompasses evaluation of innovative therapeutic approaches for children with metabolic bone disorders.
Pediatric Clinical Research
The investigator conducts studies in treatment-naïve pediatric populations, examining new therapeutic options for rare genetic disorders.
- Pediatric clinical trials
- Treatment-naïve patient studies
- Therapeutic efficacy assessment
Their work involves evaluating radiographic outcomes in pediatric patients with genetic metabolic conditions.
Therapeutic Innovation
Research activities center on investigating novel therapeutic compounds for the treatment of rare inherited metabolic disorders affecting bone development.
- Novel treatment approaches
- Placebo-controlled studies
- Radiographic outcome assessment
The investigator evaluates therapeutic interventions targeting specific metabolic pathways in pediatric bone disorders.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.